findmyKOL
Clinical trialNCT02351063TerminatedInterventional

HF Assessment With BNP in the Home: Part II

SponsorAlere San DiegoEnrollment1Heart Failure
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

HABIT-II is a feasibility study aimed at home monitoring of patients with heart failure. B-type natriuretic peptide (BNP) has strong correlations to the severity of heart failure. Lower BNP levels are closely associated with better clinical outcomes. The goal of HABIT-II is to demonstrate that the results of daily patient self-testing of BNP at home will provide sufficient information to guide physicians to modify therapy and lower BNP levels over time.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ireland
  • St. Michael'S Hospital

    Dublin, Dun Laoghaire, Ireland

Netherlands
  • University Medical Center Groningen

    Groningen, Netherlands

New Zealand
  • University of Auckland

    Auckland, New Zealand

  • Christchurch Hospital

    Christchurch, New Zealand

Sweden
  • Universitetssjukhuset Linköping

    Linköping, Sweden

United Kingdom
  • Western Infirmary

    Glasgow, United Kingdom

  • Kings College

    London, United Kingdom

United States
  • Veterans Administration Medical Center

    Loma Linda, California, United States

  • Veterans Administration Medical Center

    San Diego, California, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Veterans Administration Medical Center

    Minneapolis, Minnesota, United States

  • Ohio State University Medical Center

    Columbus, Ohio, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Changes of heart failure medications
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2014
Primary completion
31 Jul 2014
Completion
31 Jul 2014
Last update posted
3 Jan 2024
Registered enrollment
1
Registry id
NCT02351063
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.